1. FDA decision coming soon on Aimmune's contested peanut allergy drug — Roche's Tecentriq fails in bladder cancer trial — Pfizer launches biosims for Roche's 'big three' cancer drugs in the US — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice
Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What do you think of pfizer's lipitor strategy? Of course it is pissing off insurance companies and pharmacies but ultimately it benefits patients who can get the branded drug for a lower or same copayment as generics. I am not connected to it but I like that they're playing hardball and taking a chance by standing up to the insurance machine. Could this open the door to more companies bypassing insurance? Is Pfizer likely to pay a price for this? Curious what you guys think.